Abstract:We present a language-model forecasting system for merger arbitrage, a specialized high-stakes financial setting in which the task is to predict the outcome of announced M\&A deals. Unlike prior work on judgmental forecasting with LLMs, which has focused on broad mixed-topic benchmarks and short context such as news snippets, we study a setting that requires long-context reasoning over hundreds of pages of technical documents. Our system combines expert-guided context engineering with finetuning on hindsight-guided reasoning traces derived from historical deals. Given an announced deal, it outputs a probability distribution over three mutually exclusive outcomes: closing at announced terms, a higher bid, or deal termination. On an out-of-sample set of more than 400 large deals spanning 42 countries, our finetuned system achieves the best performance of any method we evaluate, reducing class-balanced Brier score to 0.151. This is 24\% below calibrated market-implied probabilities, 19\% below XGBoost, and 25-42\% below frontier language models. These results, together with ablation studies, show that LLM-based forecasting can succeed in specialized, long-context financial workflows, with hindsight-based supervision and expert-designed context playing a critical role.




Abstract:Dental disease is a prevalent chronic condition associated with substantial financial burden, personal suffering, and increased risk of systemic diseases. Despite widespread recommendations for twice-daily tooth brushing, adherence to recommended oral self-care behaviors remains sub-optimal due to factors such as forgetfulness and disengagement. To address this, we developed Oralytics, a mHealth intervention system designed to complement clinician-delivered preventative care for marginalized individuals at risk for dental disease. Oralytics incorporates an online reinforcement learning algorithm to determine optimal times to deliver intervention prompts that encourage oral self-care behaviors. We have deployed Oralytics in a registered clinical trial. The deployment required careful design to manage challenges specific to the clinical trials setting in the U.S. In this paper, we (1) highlight key design decisions of the RL algorithm that address these challenges and (2) conduct a re-sampling analysis to evaluate algorithm design decisions. A second phase (randomized control trial) of Oralytics is planned to start in spring 2025.